Pfizer to start medical trial of COVID-19 vaccine in pregnant ladies
The primary U.S. members in a large-scale medical trial to check the protection and efficacy of the Pfizer COVID-19 vaccine in pregnant ladies have acquired their pictures, the corporate introduced Thursday.
The purpose is to enroll about 4,000 pregnant ladies within the worldwide trial, which the corporate believes shall be accomplished by January 2023, CBS Information reported.
With out vaccination, analysis suggests pregnant ladies face a better danger for hospitalization and demise from COVID-19. One examine revealed in January revealed a COVID-19 mortality fee amongst pregnant ladies that was 13 instances greater than that of different equally aged sufferers, CBS Information reported.
“I recommend highly that all pregnant women be immunized, from initial discovery of the pregnancy right up to term,” Bob Lahita, M.D., a professor of drugs at New York Medical Faculty and chairman of drugs at St. Joseph College Hospital, advised CBS Information just lately. He mentioned there’s “no evidence” that the vaccine “has any effect on the placenta, on the fetus, on the mother. Except if one gets the infection, the COVID, and you are pregnant, you run the risk of becoming very, very sick.”
Pfizer additionally mentioned it plans to start out trials of the vaccine in youthful youngsters within the coming months and just lately started trials in teenagers. Analysis to evaluate the vaccine in individuals with weakened immune methods can be deliberate, CBS Information reported.
Observe the most recent information on the coronavirus (COVID-19) outbreak
CBS News Article
CBS News Article
Copyright © 2020 HealthDay. All rights reserved.
Pfizer to start medical trial of COVID-19 vaccine in pregnant ladies (2021, February 22)
retrieved 22 February 2021
This doc is topic to copyright. Other than any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.